Elixinol Wellness Limited announced the appointment of Rob Hasselman as President Americas and Beata Silber as Global Head of R&D and Innovation. The appointments are designed to drive the Company's transformation to being a global wellness business and follow a substantial body of work to reposition the business to achieve revenue growth and an accelerated path to profitability. Beata Silber joins Elixinol Wellness on 24 May 2021 from her current role as the Global Director R&D and Innovation at global health and nutrition company, H&H Group. She brings more than 20 years of experience in clinical research and over ten years' experience in the wellness innovation field, including Head of Research & Science Communications at Swisse Wellness and many years at the Head Nestle Research Centre in Switzerland. Rob Hasselman joined Elixinol on 29 April 2021 as President Americas, bringing more than 27 years of experience in the healthcare sector, including 16 years with Johnson & Johnson in sales, marketing and strategy roles.